tci Medicare Compliance & Reimbursement - 2006 Issue 26

Industry Notes: You Could Have An Easier Time Billing For Off-Label Cancer Drug Uses Soon

Beware denials that result in LUPAs Congress should expand national coverage for off-label uses of cancer drugs, the American Society of Clinical Oncology argues in the July 1 Journal of Clinical Oncology.  Congress should require Medicare contractors to consider peer-reviewed literature as they make coverage decisions about off-label cancer drugs, ASCO says. Non-Medicare insurers should follow Medicare rules on off-label cancer drug use, ASCO adds. RHHI Denies 75 Percent Of Claims With 1 Nursing, 4 Therapy Visits When you submit a claim with one nursing and four therapy visits, you'd better be ready to defend it. Regional...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.